Intercept Pharmaceuticals, Inc. (ICPT) earnings
Quarterly and annual ICPT reports and results, each read against the price at its own news timestamp. Back to the ICPT overview →
1 measured ICPT earnings event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q INTERCEPT PHARMACEUTICAL For: Sep 30 | SEC filing · Form 10-Q | -0.10% | +0.00% |
Keep exploring
More ICPT: analyst actions → · SEC filings → · ICPT overview →
Other Healthcare names and their earnings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| PharmaCyte Biotech, Inc. (PMCB) | 84 | 0.00% | 41% |
| ABATTIS BIOCEUTICALS ORD (ATTBF) | 83 | -0.24% | 41% |
| Ethos Technologies Inc. - Class A (LIFE) | 83 | -0.31% | 32% |
| COLOPLAST AS SP/ADR (CLPBY) | 82 | +0.13% | 59% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its earnings — that is what the link opens.